This tiny biotech stock is down 96% this year. Can next-gen drug testing save it?

Veraxa is shifting away from animal testing to get drugs to market faster, calling it ‘not just a regulatory obligation, but a scientific opportunity.’ ...
STAT

The end to animal testing marks the beginning of better biomedicine

Carlin is a vice president at Pathway Policy Group and a veterinarian. Paragas is the CEO and founder of DVLP Medicines and a virologist. The Food and Drug Administration’s recent decision to phase ...

VERAXA Biotech (NASDAQ: VRXA) Advances FDA-Aligned Methods to Reduce Animal Testing

VERAXA Biotech (NASDAQ: VRXA), a developer of next-generation antibody-based cancer therapies, provided an update on ...
Seeking Alpha

FDA to cut animal testing in cancer drug development

The U.S. Food and Drug Administration on Friday proposed to reduce animal studies conducted to assess safety in the development of certain cancer medications, marking the agency’s latest effort to ...
Healio

FDA to remove references to animal testing in drug safety regulations

The FDA has issued a final rule that would remove references to animal studies in its drug safety regulations, as part of a ...

FDA Updates Regulations to Advance Innovative Alternatives to Animal Testing

New rule supports wider use of innovative testing methods while maintaining existing safety standards for human drug developmentSilver Spring, MD, Sept. 21, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and ...
Medical Xpress

New paper urges caution as FDA plans to phase out animal testing in drug development

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of cheaper, safer pharmaceuticals as well as alleviating animal suffering. But ...
JD Supra

FDA animal testing phaseout urges AI-based trial alternatives, organoids, other “NAMs”

The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal antibody therapies and other drugs and biological products “with ...
Healio

FDA takes steps to reduce animal testing requirements for monoclonal antibodies

Please provide your email address to receive an email when new articles are posted on . The FDA plans to reduce and potentially replace animal testing for developing monoclonal antibody therapies and ...
UPI

To promote drug safety, FDA to replace animal testing with AI-based experiments, other methods

April 10 (UPI) --The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial intelligence, when developing monoclonal antibody therapies and ...